Autologous Biologics Market, Global Outlook and Forecast 2022-2028

August 2022 | 77 pages | ID: A5D78325AB12EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Autologous Biologics in global, including the following market information:

Global Autologous Biologics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Autologous Biologics Market Sales, 2017-2022, 2023-2028, (Kg)

Global top five Autologous Biologics companies in 2021 (%)

The global Autologous Biologics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Adipose Tissue Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Autologous Biologics include Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation and Regenexx and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autologous Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Autologous Biologics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Autologous Biologics Market Segment Percentages, by Type, 2021 (%)

• Adipose Tissue
• Plasma
• Others

Global Autologous Biologics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Autologous Biologics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Centers
• Research Centers

Global Autologous Biologics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Autologous Biologics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Autologous Biologics revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Autologous Biologics revenues share in global market, 2021 (%)

Key companies Autologous Biologics sales in global market, 2017-2022 (Estimated), (Kg)

Key companies Autologous Biologics sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Vericel Corporation
• BioTime, Inc.
• Pharmicell Co.
• BrainStorm Cell Therapeutics
• Opexa Therapeutics, Inc
• Pharmicell Co., Inc
• Neostem
• Dendreon Corporation
• Regenexx
• Cytori Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Autologous Biologics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Autologous Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AUTOLOGOUS BIOLOGICS OVERALL MARKET SIZE

2.1 Global Autologous Biologics Market Size: 2021 VS 2028
2.2 Global Autologous Biologics Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Autologous Biologics Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Autologous Biologics Players in Global Market
3.2 Top Global Autologous Biologics Companies Ranked by Revenue
3.3 Global Autologous Biologics Revenue by Companies
3.4 Global Autologous Biologics Sales by Companies
3.5 Global Autologous Biologics Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Autologous Biologics Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Autologous Biologics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Autologous Biologics Players in Global Market
  3.8.1 List of Global Tier 1 Autologous Biologics Companies
  3.8.2 List of Global Tier 2 and Tier 3 Autologous Biologics Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Autologous Biologics Market Size Markets, 2021 & 2028
  4.1.2 Adipose Tissue
  4.1.3 Plasma
  4.1.4 Others
4.2 By Type - Global Autologous Biologics Revenue & Forecasts
  4.2.1 By Type - Global Autologous Biologics Revenue, 2017-2022
  4.2.2 By Type - Global Autologous Biologics Revenue, 2023-2028
  4.2.3 By Type - Global Autologous Biologics Revenue Market Share, 2017-2028
4.3 By Type - Global Autologous Biologics Sales & Forecasts
  4.3.1 By Type - Global Autologous Biologics Sales, 2017-2022
  4.3.2 By Type - Global Autologous Biologics Sales, 2023-2028
  4.3.3 By Type - Global Autologous Biologics Sales Market Share, 2017-2028
4.4 By Type - Global Autologous Biologics Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Autologous Biologics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Centers
  5.1.4 Research Centers
5.2 By Application - Global Autologous Biologics Revenue & Forecasts
  5.2.1 By Application - Global Autologous Biologics Revenue, 2017-2022
  5.2.2 By Application - Global Autologous Biologics Revenue, 2023-2028
  5.2.3 By Application - Global Autologous Biologics Revenue Market Share, 2017-2028
5.3 By Application - Global Autologous Biologics Sales & Forecasts
  5.3.1 By Application - Global Autologous Biologics Sales, 2017-2022
  5.3.2 By Application - Global Autologous Biologics Sales, 2023-2028
  5.3.3 By Application - Global Autologous Biologics Sales Market Share, 2017-2028
5.4 By Application - Global Autologous Biologics Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Autologous Biologics Market Size, 2021 & 2028
6.2 By Region - Global Autologous Biologics Revenue & Forecasts
  6.2.1 By Region - Global Autologous Biologics Revenue, 2017-2022
  6.2.2 By Region - Global Autologous Biologics Revenue, 2023-2028
  6.2.3 By Region - Global Autologous Biologics Revenue Market Share, 2017-2028
6.3 By Region - Global Autologous Biologics Sales & Forecasts
  6.3.1 By Region - Global Autologous Biologics Sales, 2017-2022
  6.3.2 By Region - Global Autologous Biologics Sales, 2023-2028
  6.3.3 By Region - Global Autologous Biologics Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Autologous Biologics Revenue, 2017-2028
  6.4.2 By Country - North America Autologous Biologics Sales, 2017-2028
  6.4.3 US Autologous Biologics Market Size, 2017-2028
  6.4.4 Canada Autologous Biologics Market Size, 2017-2028
  6.4.5 Mexico Autologous Biologics Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Autologous Biologics Revenue, 2017-2028
  6.5.2 By Country - Europe Autologous Biologics Sales, 2017-2028
  6.5.3 Germany Autologous Biologics Market Size, 2017-2028
  6.5.4 France Autologous Biologics Market Size, 2017-2028
  6.5.5 U.K. Autologous Biologics Market Size, 2017-2028
  6.5.6 Italy Autologous Biologics Market Size, 2017-2028
  6.5.7 Russia Autologous Biologics Market Size, 2017-2028
  6.5.8 Nordic Countries Autologous Biologics Market Size, 2017-2028
  6.5.9 Benelux Autologous Biologics Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Autologous Biologics Revenue, 2017-2028
  6.6.2 By Region - Asia Autologous Biologics Sales, 2017-2028
  6.6.3 China Autologous Biologics Market Size, 2017-2028
  6.6.4 Japan Autologous Biologics Market Size, 2017-2028
  6.6.5 South Korea Autologous Biologics Market Size, 2017-2028
  6.6.6 Southeast Asia Autologous Biologics Market Size, 2017-2028
  6.6.7 India Autologous Biologics Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Autologous Biologics Revenue, 2017-2028
  6.7.2 By Country - South America Autologous Biologics Sales, 2017-2028
  6.7.3 Brazil Autologous Biologics Market Size, 2017-2028
  6.7.4 Argentina Autologous Biologics Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Autologous Biologics Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Autologous Biologics Sales, 2017-2028
  6.8.3 Turkey Autologous Biologics Market Size, 2017-2028
  6.8.4 Israel Autologous Biologics Market Size, 2017-2028
  6.8.5 Saudi Arabia Autologous Biologics Market Size, 2017-2028
  6.8.6 UAE Autologous Biologics Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Vericel Corporation
  7.1.1 Vericel Corporation Corporate Summary
  7.1.2 Vericel Corporation Business Overview
  7.1.3 Vericel Corporation Autologous Biologics Major Product Offerings
  7.1.4 Vericel Corporation Autologous Biologics Sales and Revenue in Global (2017-2022)
  7.1.5 Vericel Corporation Key News
7.2 BioTime, Inc.
  7.2.1 BioTime, Inc. Corporate Summary
  7.2.2 BioTime, Inc. Business Overview
  7.2.3 BioTime, Inc. Autologous Biologics Major Product Offerings
  7.2.4 BioTime, Inc. Autologous Biologics Sales and Revenue in Global (2017-2022)
  7.2.5 BioTime, Inc. Key News
7.3 Pharmicell Co.
  7.3.1 Pharmicell Co. Corporate Summary
  7.3.2 Pharmicell Co. Business Overview
  7.3.3 Pharmicell Co. Autologous Biologics Major Product Offerings
  7.3.4 Pharmicell Co. Autologous Biologics Sales and Revenue in Global (2017-2022)
  7.3.5 Pharmicell Co. Key News
7.4 BrainStorm Cell Therapeutics
  7.4.1 BrainStorm Cell Therapeutics Corporate Summary
  7.4.2 BrainStorm Cell Therapeutics Business Overview
  7.4.3 BrainStorm Cell Therapeutics Autologous Biologics Major Product Offerings
  7.4.4 BrainStorm Cell Therapeutics Autologous Biologics Sales and Revenue in Global (2017-2022)
  7.4.5 BrainStorm Cell Therapeutics Key News
7.5 Opexa Therapeutics, Inc
  7.5.1 Opexa Therapeutics, Inc Corporate Summary
  7.5.2 Opexa Therapeutics, Inc Business Overview
  7.5.3 Opexa Therapeutics, Inc Autologous Biologics Major Product Offerings
  7.5.4 Opexa Therapeutics, Inc Autologous Biologics Sales and Revenue in Global (2017-2022)
  7.5.5 Opexa Therapeutics, Inc Key News
7.6 Pharmicell Co., Inc
  7.6.1 Pharmicell Co., Inc Corporate Summary
  7.6.2 Pharmicell Co., Inc Business Overview
  7.6.3 Pharmicell Co., Inc Autologous Biologics Major Product Offerings
  7.6.4 Pharmicell Co., Inc Autologous Biologics Sales and Revenue in Global (2017-2022)
  7.6.5 Pharmicell Co., Inc Key News
7.7 Neostem
  7.7.1 Neostem Corporate Summary
  7.7.2 Neostem Business Overview
  7.7.3 Neostem Autologous Biologics Major Product Offerings
  7.7.4 Neostem Autologous Biologics Sales and Revenue in Global (2017-2022)
  7.7.5 Neostem Key News
7.8 Dendreon Corporation
  7.8.1 Dendreon Corporation Corporate Summary
  7.8.2 Dendreon Corporation Business Overview
  7.8.3 Dendreon Corporation Autologous Biologics Major Product Offerings
  7.8.4 Dendreon Corporation Autologous Biologics Sales and Revenue in Global (2017-2022)
  7.8.5 Dendreon Corporation Key News
7.9 Regenexx
  7.9.1 Regenexx Corporate Summary
  7.9.2 Regenexx Business Overview
  7.9.3 Regenexx Autologous Biologics Major Product Offerings
  7.9.4 Regenexx Autologous Biologics Sales and Revenue in Global (2017-2022)
  7.9.5 Regenexx Key News
7.10 Cytori Therapeutics
  7.10.1 Cytori Therapeutics Corporate Summary
  7.10.2 Cytori Therapeutics Business Overview
  7.10.3 Cytori Therapeutics Autologous Biologics Major Product Offerings
  7.10.4 Cytori Therapeutics Autologous Biologics Sales and Revenue in Global (2017-2022)
  7.10.5 Cytori Therapeutics Key News

8 GLOBAL AUTOLOGOUS BIOLOGICS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Autologous Biologics Production Capacity, 2017-2028
8.2 Autologous Biologics Production Capacity of Key Manufacturers in Global Market
8.3 Global Autologous Biologics Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 AUTOLOGOUS BIOLOGICS SUPPLY CHAIN ANALYSIS

10.1 Autologous Biologics Industry Value Chain
10.2 Autologous Biologics Upstream Market
10.3 Autologous Biologics Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Autologous Biologics Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Autologous Biologics in Global Market
Table 2. Top Autologous Biologics Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Autologous Biologics Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Autologous Biologics Revenue Share by Companies, 2017-2022
Table 5. Global Autologous Biologics Sales by Companies, (Kg), 2017-2022
Table 6. Global Autologous Biologics Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Autologous Biologics Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Autologous Biologics Product Type
Table 9. List of Global Tier 1 Autologous Biologics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autologous Biologics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Autologous Biologics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Autologous Biologics Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Autologous Biologics Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Autologous Biologics Sales (Kg), 2017-2022
Table 15. By Type - Global Autologous Biologics Sales (Kg), 2023-2028
Table 16. By Application – Global Autologous Biologics Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Autologous Biologics Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Autologous Biologics Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Autologous Biologics Sales (Kg), 2017-2022
Table 20. By Application - Global Autologous Biologics Sales (Kg), 2023-2028
Table 21. By Region – Global Autologous Biologics Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Autologous Biologics Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Autologous Biologics Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Autologous Biologics Sales (Kg), 2017-2022
Table 25. By Region - Global Autologous Biologics Sales (Kg), 2023-2028
Table 26. By Country - North America Autologous Biologics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Autologous Biologics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Autologous Biologics Sales, (Kg), 2017-2022
Table 29. By Country - North America Autologous Biologics Sales, (Kg), 2023-2028
Table 30. By Country - Europe Autologous Biologics Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Autologous Biologics Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Autologous Biologics Sales, (Kg), 2017-2022
Table 33. By Country - Europe Autologous Biologics Sales, (Kg), 2023-2028
Table 34. By Region - Asia Autologous Biologics Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Autologous Biologics Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Autologous Biologics Sales, (Kg), 2017-2022
Table 37. By Region - Asia Autologous Biologics Sales, (Kg), 2023-2028
Table 38. By Country - South America Autologous Biologics Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Autologous Biologics Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Autologous Biologics Sales, (Kg), 2017-2022
Table 41. By Country - South America Autologous Biologics Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Autologous Biologics Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Autologous Biologics Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Autologous Biologics Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Autologous Biologics Sales, (Kg), 2023-2028
Table 46. Vericel Corporation Corporate Summary
Table 47. Vericel Corporation Autologous Biologics Product Offerings
Table 48. Vericel Corporation Autologous Biologics Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. BioTime, Inc. Corporate Summary
Table 50. BioTime, Inc. Autologous Biologics Product Offerings
Table 51. BioTime, Inc. Autologous Biologics Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. Pharmicell Co. Corporate Summary
Table 53. Pharmicell Co. Autologous Biologics Product Offerings
Table 54. Pharmicell Co. Autologous Biologics Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. BrainStorm Cell Therapeutics Corporate Summary
Table 56. BrainStorm Cell Therapeutics Autologous Biologics Product Offerings
Table 57. BrainStorm Cell Therapeutics Autologous Biologics Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. Opexa Therapeutics, Inc Corporate Summary
Table 59. Opexa Therapeutics, Inc Autologous Biologics Product Offerings
Table 60. Opexa Therapeutics, Inc Autologous Biologics Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Pharmicell Co., Inc Corporate Summary
Table 62. Pharmicell Co., Inc Autologous Biologics Product Offerings
Table 63. Pharmicell Co., Inc Autologous Biologics Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. Neostem Corporate Summary
Table 65. Neostem Autologous Biologics Product Offerings
Table 66. Neostem Autologous Biologics Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Dendreon Corporation Corporate Summary
Table 68. Dendreon Corporation Autologous Biologics Product Offerings
Table 69. Dendreon Corporation Autologous Biologics Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Regenexx Corporate Summary
Table 71. Regenexx Autologous Biologics Product Offerings
Table 72. Regenexx Autologous Biologics Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Cytori Therapeutics Corporate Summary
Table 74. Cytori Therapeutics Autologous Biologics Product Offerings
Table 75. Cytori Therapeutics Autologous Biologics Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 76. Autologous Biologics Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 77. Global Autologous Biologics Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Autologous Biologics Production by Region, 2017-2022 (Kg)
Table 79. Global Autologous Biologics Production by Region, 2023-2028 (Kg)
Table 80. Autologous Biologics Market Opportunities & Trends in Global Market
Table 81. Autologous Biologics Market Drivers in Global Market
Table 82. Autologous Biologics Market Restraints in Global Market
Table 83. Autologous Biologics Raw Materials
Table 84. Autologous Biologics Raw Materials Suppliers in Global Market
Table 85. Typical Autologous Biologics Downstream
Table 86. Autologous Biologics Downstream Clients in Global Market
Table 87. Autologous Biologics Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Autologous Biologics Segment by Type
Figure 2. Autologous Biologics Segment by Application
Figure 3. Global Autologous Biologics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Autologous Biologics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Autologous Biologics Revenue, 2017-2028 (US$, Mn)
Figure 7. Autologous Biologics Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Autologous Biologics Revenue in 2021
Figure 9. By Type - Global Autologous Biologics Sales Market Share, 2017-2028
Figure 10. By Type - Global Autologous Biologics Revenue Market Share, 2017-2028
Figure 11. By Type - Global Autologous Biologics Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Autologous Biologics Sales Market Share, 2017-2028
Figure 13. By Application - Global Autologous Biologics Revenue Market Share, 2017-2028
Figure 14. By Application - Global Autologous Biologics Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Autologous Biologics Sales Market Share, 2017-2028
Figure 16. By Region - Global Autologous Biologics Revenue Market Share, 2017-2028
Figure 17. By Country - North America Autologous Biologics Revenue Market Share, 2017-2028
Figure 18. By Country - North America Autologous Biologics Sales Market Share, 2017-2028
Figure 19. US Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Autologous Biologics Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Autologous Biologics Sales Market Share, 2017-2028
Figure 24. Germany Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 25. France Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Autologous Biologics Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Autologous Biologics Sales Market Share, 2017-2028
Figure 33. China Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 37. India Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Autologous Biologics Revenue Market Share, 2017-2028
Figure 39. By Country - South America Autologous Biologics Sales Market Share, 2017-2028
Figure 40. Brazil Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Autologous Biologics Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Autologous Biologics Sales Market Share, 2017-2028
Figure 44. Turkey Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Autologous Biologics Revenue, (US$, Mn), 2017-2028
Figure 48. Global Autologous Biologics Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Autologous Biologics by Region, 2021 VS 2028
Figure 50. Autologous Biologics Industry Value Chain
Figure 51. Marketing Channels